Eosinophilic esophagitis in children with esophageal atresia

Diseases of the Esophagus

Volumn 27, Issue 4, 2014, Pages 340-347

  Dhaliwal, J ^a   Tobias, V ^a   Sugo, E ^a   Varjavandi, V ^a,b   Lemberg, D ^a,b   Day, A ^a,b   Bohane, T ^a,b   Ledder, O ^a   Jiwane, A ^a,b   Adams, S ^a,b   Henry, G ^a,b   Dilley, A ^a,b   Shi, E ^a,b   Krishnan, U ^a,b  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Esoinophilic esophagitis; Esophageal atresia; Stricture

Indexed keywords

BUDESONIDE; FLUTICASONE; PROTON PUMP INHIBITOR;

AORTA SURGERY; ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS ATRESIA; ESOPHAGUS BIOPSY; ESOPHAGUS STENOSIS; FEMALE; FOOD ALLERGY; GASTROSTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH FUNDOPLICATION; COHORT ANALYSIS; DEGLUTITION DISORDERS; ESOPHAGEAL STENOSIS; ESOPHAGUS; FOOD HYPERSENSITIVITY; PATHOLOGY; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; TRACHEOESOPHAGEAL FISTULA; TRACHEOMALACIA;

ASTHMA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEGLUTITION DISORDERS; EOSINOPHILIC ESOPHAGITIS; ESOPHAGEAL STENOSIS; ESOPHAGUS; FEMALE; FOOD HYPERSENSITIVITY; FUNDOPLICATION; GASTROSTOMY; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; TRACHEOESOPHAGEAL FISTULA; TRACHEOMALACIA;

EID: 84899493100     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12119     Document Type: Article

References (32)

1. Little D C, Rescorla F J, Grosfeld K W, West L R, Scherer L R, Engum S A. Long term analysis of children with esophageal atresia and tracheoesophageal fistula. J Paediatr Surg 2003; 38: 852-856.
2. Liacouras C A, Furuta G T, Hirano I etal. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128 (1): 3-20.
3. Oliveira C, Zamakhshary M, Marcon P, Kim P C W. Eosinophilic esophagitis and intermediate esophagitis after tracheoesophageal fistula repair. A case series. J Paediatr Surg 2008; 43: 810-814.
4. Gorter R R, Heij H A, Van der Voorn P J, Kneepkens C M. Eosinophilic esophagitis after esophageal atresia: is there an association? Case presentation and literature review. J Pediatr Surg 2012; 47: E9-E13.
5. Batres L A, Liacouras C, Schnaufer L, Mascarenhas M R. Eosinophilic esophagitis associated with anastomotic strictures after esophageal atresia repair. J Pediatr Gastroenterol Nutr 2002; 35: 224-226.
6. Noel R J, Putnam P E, Rothenberg M E. Eosinophilic esophagitis. N Engl J Med 2004; 351: 940-941.
7. Spitz L. Esophageal atresia: lessons I have learned in a 40 year experience. J Pediatr Surg 2006; 41: 1635-1640.
8. Konkin D E, O'hali W A, Webber E M, Blair G K. Outcomes in esophageal atresia and tracheoesophageal fistula. J Pediatr Surg 2003; 38: 1726-1729.
9. Parker A F, Christie D L, Cahill J L. Incidence and significance of gastroesophageal reflux following repair of esophageal atresia and tracheoesophageal fistula and the need for anti-reflux procedures. J Pediatr Surg 1979; 14 (1): 5-8.
10. Shermeta D W, Whitington P F, Seto D S, Haller J A. Lower esophageal sphincter dysfunction in esophageal atresia: nocturnal regurgitation and aspiration pneumonia. J Pediatr Surg 1977; 12: 871-876.
11. Mckinnon L J, Kosloske A M. Prediction and prevention of anastomotic complications of esophageal atresia and tracheoesophageal fistula. J Pediatr Surg 1990; 25: 778-781.
12. Aceves S S, Newbury R O, Chen D etal. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 2010; 65 (1): 109-116.
13. Spergel J M, Brown-Whitehorn T F, Cianferoni A etal. Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet. J Allergy Clin Immunol 2012; 130 (2): 461-475.
14. Dohil R, Newbury R, Fox L, Bastian J, Aceves S. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 2010; 139: 418-429.
15. Konikoff M R, Noel R J, Blanchard C etal. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006; 131: 1381-1391.
16. Aceves S S, Bastian J F, Newbury R O, Dohil R. Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol 2007; 102: 2271-2279.
17. Dohil R, Newbury R O. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis. Dig Dis Sci 2012; 57: 1413-1419.
18. Kedika R R, Souza R F, Spechler S J. Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci 2009; 54: 2312-2317.
19. Biswas K, Bandyopadhyay U, Chattopadhyay I, Varadaraj A, Ali E, Banerjee R K. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem 2003; 278: 10993-11001.
20. Cheng E, Zhang X, Huo X etal. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut 2012; 62: 824-832.
21. Straumann A, Bauer M, Fischer B, Blaser K, Simon H U. Idiopathic eosinophilic esophagitis is associated with a T-helper 2 type allergic inflammatory response. J Allergy Clin Immunol 2001; 108: 954-961.
22. Bullock J Z, Villanueva J M, Blanchard C etal. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2007; 45 (1): 22-31.
23. Blanchard C, Mingler M K, Vicario M etal. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 2007; 120: 1292-1300.
24. Bhattacharya B, Carlsten J, Sabo E etal. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease. Hum Pathol 2007; 38: 1744-1753.
25. Stankiewicz P, Sen P, Bhatt S S. Genomic and genetic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am J Hum Genet 2009; 84: 780-791.
26. Shaw-Smith C. Genetic factors in esophageal atresia, tracheoesophageal fistula and the Vacteral association: roles for FOXF1 and the 16q24.1 FOX transcription factor gene cluster, and review of the literature. Eur J Med Genet 2010; 53: 6-13.
27. Lou Y, Lu X, Dang X. FOXO1 up-regulates human l-selectin expression through binding to a consensus FOXO1 motif. Gene Regul Syst Biol 2012; 6: 139-149.
28. Tobey N A, Carson J L, Alkiek R A, Orlando R C. Dilated intercellular spaces: a morphological feature of acid reflux - damaged human esophageal epithelium. Gastroenterology 1996; 111: 1200-1205.
29. Allen K J, Heine R G. Eosinophilic eosphagitis: trials and tribulations. J Clin Gastroenterol 2011; 45: 574-582.
30. Untersmayr E, Jensen-Jarolim E. The role of protein digestibility and antacids on food allergy outcomes. J Allergy Clin Immunol 2008; 121: 1301-1308.
31. Diesner S C, Knittelfelder R, Krishnamurthy D etal. Dose-dependent food allergy induction against ovalbumin under acid-suppression: a murine food allergy model. Immunol Lett 2008; 121 (1): 45-51.
32. Untersmayr E, Schöll I, Swoboda I etal. Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB/c mice. J Allergy Clin Immunol 2003; 112: 616-623.